AzTrials
AzTrials

Explicit Recall of Intra-operative EventsPhase 2/3NCT00281489

Study Evaluating Ways of Preventing Patients From Being Awake During High-Risk Surgery and Anesthesia

A Phase 2/3 study testing BIS Monitor guided algorithm and Volatile anesthetic guided algorithm in people with Explicit Recall of Intra-operative Events, run by Washington University School of Medicine at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able measure how asleep a patient is during surgery. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
BIS Monitor guided algorithm and Volatile anesthetic guided algorithm
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,000 participants
Where
1 siteUnited States
Study dates
Aug 2005to Oct 2006
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • MUST HAVE:
  • General Anesthesia with volatile anesthetic
  • PATIENT CHARACTERISTICS
  • Major Criteria (any 1 of the following:)
  • Medications - anticonvulsants, abuse of opiates, benzodiazepines, cocaine
  • EF<40%
Show all 20Show fewer
  • Prior history of awareness (recall)
  • History of difficult intubation or anticipated difficult intubation
  • ASA IV or V status
  • Aortic stenosis
  • End stage lung disease
  • Marginal exercise tolerance not secondary to musculoskeletal dysfunction
  • Pulmonary hypertension
  • Daily alcohol consumption
  • Minor Criteria (any 2 of the following)
  • Beta blockers
  • COPD
  • Moderate exercise tolerance not secondary to musculoskeletal dysfunction
  • Smokes ≥2 packs per day
  • Morbid obesity BMI>30 -

Who cannot join

  • Surgical procedure that prevents the use of the BIS (e.g surgery of forehead)
  • Patient positioning prevents use of the BIS
  • Surgery with wake-up test.
  • Less than 18 years of age
  • Vulnerable populations, such as those with dementia and those unable to provide informed consent.
  • Stroke with residual neurological deficits

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Barnes-Jewish Hospital

    St Louis, Missouri, 63110

Other trials in United States

About this study

Official title: B-Unaware Study: Comparison of BIS-guided Anesthesia With End-Tidal Volatile-Guided Anesthesia to Decrease The Incidence of Awareness During High-Risk Surgery

The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able measure how asleep a patient is during surgery. Using the BIS monitor to guide anesthesia will be compared with using the concentration of anesthetic gas to guide anesthesia.

Read the detailed description

General anesthesia is a state of drug-induced unconsciousness, during which patients should neither perceive nor recall noxious stimuli. Many patients facing surgery dread the prospect of being awake, in pain and unable to move owing to inadequate general anesthesia. A large multi-center study in the USA showed that, despite modern anesthesia techniques, the overall incidence of awareness or conscious recall remains about 0.1-0.2%. For high-risk (for awareness) surgery, such as cardiac surgery, trauma surgery and obstetric surgery, the incidence of conscious recall approaches 1%. This can lead to extreme anxiety and even posttraumatic stress disorder. Several monitors, including the Bispectral Index (BIS), which is based on processed electroencephalographic information, have been developed in an attempt to monitor depth of anesthesia. A recent landmark study suggested that harnessing the information provided by the BIS monitor decreases the incidence of explicit recall during high-risk surgical procedures from almost 1% to 0.1%. The possible impact of this study is enormous. The American Society of Anesthesiologists and the American Association of Nurse Anesthetists do not currently consider neurological monitors an essential part of routine anesthesia care. Increasingly, members of the anesthetic community are suggesting that for every patient undergoing general anesthesia, especially for procedures where the risk of awareness is considered higher, a neurological monitor, such as the BIS monitor, should be routinely applied.

Explicit recall under general anesthesia is a major concern among members of the public and has even been featured on the popular Oprah Winfrey Show. Several patients presenting for surgery at Barnes Jewish Hospital have questioned whether the anesthesia provider would be using a BIS monitor to "prevent awareness". Excluding the cost of the BIS monitor itself, the cost to use BIS is $17.50 for the disposable strip. If this monitor was to be used for every anesthetic administered at Barnes Jewish Hospital, this might translate to an annual cost of about $500,000. Explicit recall, especially when patients have been aware and unable to move, is a serious complication that frequently precipitates posttraumatic stress disorder. If indeed the BIS monitor does decrease the incidence of explicit recall, this could translate into a cost effective and more importantly clinically imperative intervention. Currently BIS monitors, or similar alternatives, are not used routinely to monitor depth of general anesthesia at Barnes Jewish Hospital.

However, there are several concerns regarding the studies that have been conducted using the BIS monitor. There have been no parameters guiding administration of anesthesia in the control groups. BIS data have not been collected for patients in control groups, which prevents retrospective analysis and assessment of the true sensitivity, specificity, positive and negative predictive values of the BIS recordings. Most of the studies have been funded by the manufacturer of the device, which introduces a potential conflict of interest and investigator bias. In view of the current pressure to adopt BIS monitoring or an equivalent into the standard of anesthesia care, it is essential to conduct a study to address some of the concerns. The hypothesis of this proposed study is that an anesthetic algorithm can be designed for high-risk surgical patients such that the incidence of awareness will be equivalent to or lower than that in a group where anesthesia depth is guided by the BIS monitor.

Being tested
BIS Monitor guided algorithm, Volatile anesthetic guided algorithm
Keywords
Recall, Awareness, BIS, Anesthesia, Explicit Recall

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BIS Monitor guided algorithmDevice

    BIS guided algorithm (BIS target 40 to 60) during anesthesia. Alarms when BIS is outside this range.

  • Volatile anesthetic guided algorithmBehavioural

    Volatile anesthetic guided algorithm. Target anesthetic concentration 0.7 to 1.3 minimum alveolar concentration during anesthesia. Alarms when anesthetic concentration not in this range.

Study groups in NCT00281489
Study groupRoleWhat they receive
BIS Monitor guided algorithmExperimentalBIS guided algorithm (BIS target 40 to 60) during anesthesia. Alarms when BIS is outside this range.
Receives: Device: BIS Monitor guided algorithm
Volatile anesthetic guided algorithmActive comparatorVolatile anesthetic guided algorithm. Target anesthetic concentration 0.7 to 1.3 minimum alveolar concentration during anesthesia. Alarms when anesthetic concentration not in this range.
Receives: Behavioral: Volatile anesthetic guided algorithm

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The incidence of explicit recall of events during the surgical and anesthetic periods.

    Measured: 30 days

Secondary outcomes (7)
  1. 1 Anesthetic concentrations & BIS values in each group.

    Measured: 1 day

  2. 2 Implicit memory (number).

    Measured: 30 days

  3. 3 Dreaming.

    Measured: 30 days

  4. 4 One-year mortality (and "anesthetic depth").

    Measured: 1 year

  5. 5 Relation of assessment to BIS value.

    Measured: 30 days

  6. 6 Relation of events (e.g. movement) to BIS & ETAG.

    Measured: 1 day

  7. 7 Relation of EMG to BIS.

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jan 2006 (estimated)
  2. Study startAug 2005
  3. Primary completionOct 2006

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
2,000 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00281489
Sponsor's protocol ID
04-1112
Status last verified
Jul 2012
First submitted
20 Jan 2006
Last updated
23 Jul 2012
Results posted
No

Publications

  • Myles PS, Leslie K, McNeil J, Forbes A, Chan MT. Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. Lancet. 2004 May 29;363(9423):1757-63. doi: 10.1016/S0140-6736(04)16300-9.

    PubMed 15172773
  • Willingham M, Ben Abdallah A, Gradwohl S, Helsten D, Lin N, Villafranca A, Jacobsohn E, Avidan M, Kaiser H. Association between intraoperative electroencephalographic suppression and postoperative mortality. Br J Anaesth. 2014 Dec;113(6):1001-8. doi: 10.1093/bja/aeu105. Epub 2014 May 22.

    PubMed 24852500
  • Avidan MS, Palanca BJ, Glick D, Jacobsohn E, Villafranca A, O'Connor M, Mashour GA; BAG-RECALL Study Group. Protocol for the BAG-RECALL clinical trial: a prospective, multi-center, randomized, controlled trial to determine whether a bispectral index-guided protocol is superior to an anesthesia gas-guided protocol in reducing intraoperative awareness with explicit recall in high risk surgical patients. BMC Anesthesiol. 2009 Nov 30;9:8. doi: 10.1186/1471-2253-9-8.

    PubMed 19948045
  • Avidan MS, Zhang L, Burnside BA, Finkel KJ, Searleman AC, Selvidge JA, Saager L, Turner MS, Rao S, Bottros M, Hantler C, Jacobsohn E, Evers AS. Anesthesia awareness and the bispectral index. N Engl J Med. 2008 Mar 13;358(11):1097-108. doi: 10.1056/NEJMoa0707361.

    PubMed 18337600

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing BIS Monitor guided algorithm and Volatile anesthetic guided algorithm in people with Explicit Recall of Intra-operative Events, run by Washington University School of Medicine at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 20 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Jul 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The incidence of explicit recall of events during the surgical and anesthetic periods. (time frame: 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00281489, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in